Surgical models of hypertrophy and heart failure: Myocardial infarction and transverse aortic constriction

Drug Discovery Today: Disease Models

Volumn 3, Issue 3, 2006, Pages 283-290

  Lygate, Craig ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; AORTA CONSTRICTION; COMPUTER MODEL; CORONARY ARTERY LIGATION; DISEASE COURSE; EX VIVO STUDY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RAT; REVIEW;

EID: 33751233538     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.002     Document Type: Review

References (41)

1. Eriksson H. Heart failure: a growing public health problem. J. Internal Med. 237 (1995) 135-141
2. Kupari M., et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki ageing study. J. Internal Med. 241 (1997) 387-394
3. Weir R.A., et al. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am. J. Cardiol. 97 (2006) 13F-25F
4. Philipp S., et al. Animal models for the study of myocardial protection against ischemia. Drug Discov. Today: Dis. Models 2 (2005) 219-225
5. Selye H., et al. Simple techniques for the surgical occlusion of coronary vessels in rats. Angiology 11 (1960) 398-407
6. Pfeffer M.A., et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72 (1985) 406-412
7. Sutton M.S.J., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction - baseline predictors and impact of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) trial. Circulation 96 (1997) 3294-3299
8. Zolotareva A.G., and Kogan M.E. Production of experimental occlusive myocardial infarction in mice. Cor. Vasa. 20 (1978) 308-314
9. Lygate C.A., and Neubauer S. Surgically induced chronic heart failure. In: Xu Q. (Ed). A Handbook of Mouse Models of Cardiovascular Disease (2006), Wiley 333-348
10. Barrett T.D., et al. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias. Eur. J. Pharmacol. 285 (1995) 229-238
11. Hayashidani S., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1229-H1235
12. Gao X.M., et al. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc. Res. 65 (2005) 469-477
13. Ertl G., and Frantz S. Healing after myocardial infarction. Cardiovasc. Res. 66 (2005) 22-32
14. In: Hoit B.D., and Walsh R.A. (Eds). Cardiovascular Physiology in the Genetically Engineered Mouse (2002), Kluwer Academic Publishers
15. Dawson D., et al. Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice. Circulation 110 (2004) 1632-1637
16. Takaoka H., et al. Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H2190-H2197
17. Ahn D., et al. Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1201-H1207
18. van den Bos E.J., et al. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1291-H1300
19. Liao R., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106 (2002) 2125-2131
20. Rockman H.A., et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl Acad. Sci. U S A 88 (1991) 8277-8281
21. Hara M., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195 (2002) 375-381
22. Hu P., et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1261-H1269
23. Nakamura A., et al. LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1104-H1112
24. Liao Y., et al. Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1703-H1708
25. Skavdahl M., et al. Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H469-H476
26. Lygate C.A., et al. Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res. Cardiol. 101 (2006) 8-16
27. Isoyama S., et al. Collagen deposition and the reversal of coronary reserve in cardiac hypertrophy. Hypertension 20 (1992) 491-500
28. Schaub M.C., et al. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J. Mol. Med. 75 (1997) 901-920
29. Noble D. Modeling the heart-from genes to cells to the whole organ. Science 295 (2002) 1678-1682
30. Patten R.D., et al. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin. Sci. (Lond.) 104 (2003) 109-118
31. Deten A., and Zimmer H.G. Heart function and cytokine expression is similar in mice and rats after myocardial infarction but differences occur in TNFalpha expression. Pflugers Arch. 445 (2002) 289-296
32. Gould K.E., et al. Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H615-H621
33. Lygate C.A., et al. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. Cardiovasc. Res. 58 (2003) 632-637
34. Dawson D., et al. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112 (2005) 3729-3737
35. Okada H., et al. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111 (2005) 2430-2437
36. Uemura R., et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
37. Hama N., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
38. Palojoki E., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2726-H2731
39. Ten Hove M., et al. Mechanisms of creatine depletion in chronically failing rat heart. J. Mol. Cell. Cardiol. 38 (2005) 309-313
40. Gao X.M., et al. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc. Res. 65 (2005) 469-477
41. Sakaguchi G., et al. Left ventricular aneurysm repair in rats: structural, functional, and molecular consequences. J. Thorac. Cardiovasc. Surg. 121 (2001) 750-761